These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32628750)

  • 1. Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.
    Stubblefield WB; Talbot HK; Feldstein LR; Tenforde MW; Ur Rasheed MA; Mills L; Lester SN; Freeman B; Thornburg NJ; Jones ID; Ward MJ; Lindsell CJ; Baughman A; Halasa N; Grijalva CG; Rice TW; Patel MM; Self WH
    Clin Infect Dis; 2021 May; 72(9):1645-1648. PubMed ID: 32628750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
    Self WH; Tenforde MW; Stubblefield WB; Feldstein LR; Steingrub JS; Shapiro NI; Ginde AA; Prekker ME; Brown SM; Peltan ID; Gong MN; Aboodi MS; Khan A; Exline MC; Files DC; Gibbs KW; Lindsell CJ; Rice TW; Jones ID; Halasa N; Talbot HK; Grijalva CG; Casey JD; Hager DN; Qadir N; Henning DJ; Coughlin MM; Schiffer J; Semenova V; Li H; Thornburg NJ; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1221-1226. PubMed ID: 32881855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.
    Shields A; Faustini SE; Perez-Toledo M; Jossi S; Aldera E; Allen JD; Al-Taei S; Backhouse C; Bosworth A; Dunbar LA; Ebanks D; Emmanuel B; Garvey M; Gray J; Kidd IM; McGinnell G; McLoughlin DE; Morley G; O'Neill J; Papakonstantinou D; Pickles O; Poxon C; Richter M; Walker EM; Wanigasooriya K; Watanabe Y; Whalley C; Zielinska AE; Crispin M; Wraith DC; Beggs AD; Cunningham AF; Drayson MT; Richter AG
    Thorax; 2020 Dec; 75(12):1089-1094. PubMed ID: 32917840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Survey Among 17 971 Healthcare and Administrative Personnel at Hospitals, Prehospital Services, and Specialist Practitioners in the Central Denmark Region.
    Jespersen S; Mikkelsen S; Greve T; Kaspersen KA; Tolstrup M; Boldsen JK; Redder JD; Nielsen K; Abildgaard AM; Kolstad HA; Østergaard L; Thomsen MK; Møller HJ; Erikstrup C
    Clin Infect Dis; 2021 Nov; 73(9):e2853-e2860. PubMed ID: 33011792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.
    Patel MM; Thornburg NJ; Stubblefield WB; Talbot HK; Coughlin MM; Feldstein LR; Self WH
    JAMA; 2020 Nov; 324(17):1781-1782. PubMed ID: 32940635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.
    Bouwman M; van Osch F; Crijns F; Trienekens T; Mehagnoul-Schipper J; van den Bergh JP; de Vries J
    BMJ Open; 2021 Oct; 11(10):e051573. PubMed ID: 34663664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia.
    Lau JS; Buntine P; Price M; Darzins P; Newnham E; Connell A; Chean R; Edwards G; Guy S
    Infect Dis Health; 2021 Aug; 26(3):208-213. PubMed ID: 33903074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey.
    Johnson A; Vincent B; Carson P; Skoy E
    J Am Pharm Assoc (2003); 2021; 61(3):e127-e132. PubMed ID: 33568267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 seroprevalence in hospital healthcare workers in Western Switzerland at the end of the second pandemic wave.
    Jacot D; von Rotz U; Blondet F; Aebischer O; Matthieu P; De Rham M; Pantaleo G; Marchetti O; Greub G
    J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35921229
    [No Abstract]   [Full Text] [Related]  

  • 10. Half-Year Longitudinal Seroprevalence of SARS-CoV-2-Antibodies and Rule Compliance in German Hospital Employees.
    Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrecognized severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare personnel in a low-prevalence area.
    Shah VP; Hainy CM; Swift MD; Breeher LE; Theel ES; Sampathkumar P
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1532-1534. PubMed ID: 33213552
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey.
    Oygar PD; Büyükçam A; Bal ZŞ; Dalgıç N; Bozdemir ŞE; Karbuz A; Çetin BŞ; Kara Y; Çetin C; Hatipoğlu N; Uygun H; Aygün FD; Törün SH; Okur DŞ; Çiftdoğan DY; Kara TT; Yahşi A; Özer A; Demir SÖ; Akkoç G; Turan C; Salı E; Şen S; Erdeniz EH; Kara SS; Emiroğlu M; Erat T; Aktürk H; Gürlevik SL; Sütçü M; Aydın ZGG; Atikan BY; Yeşil E; Güner G; Çelebi E; Efe K; İşançlı DK; Durmuş HS; Tekeli S; Karaaslan A; Bülbül L; Almış H; Kaba Ö; Keleş YE; Yazıcıoğlu B; Oğuz ŞB; Ovalı HF; Doğan HH; Çelebi S; Çakır D; Karasulu B; Alkan G; Yenidoğan İ; Gül D; Küçükalioğlu BP; Avcu G; Kukul MG; Bilen M; Yaşar B; Üstün T; Kılıç Ö; Akın Y; Cebeci SO; Bucak IH; Yanartaş MS; Şahin A; Arslanoğlu S; Elevli M; Çoban R; Öz ŞKT; Hatipoğlu H; Erkum İT; Turgut M; Demirbuğa A; Özçelik T; Çiftçi D; Sarı EE; Akkuş G; Hatipoğlu SS; Dinleyici EÇ; Hacımustafaoğlu M; Özkınay F; Kurugöl Z; Cengiz AB; Somer A; Tezer H; Kara A
    Int J Infect Dis; 2021 Dec; 113():184-189. PubMed ID: 34592441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo.
    Mukwege D; Byabene AK; Akonkwa EM; Dahma H; Dauby N; Cikwanine Buhendwa JP; Le Coadou A; Montesinos I; Bruyneel M; Cadière GB; Vandenberg O; Van Laethem Y
    Am J Trop Med Hyg; 2021 Feb; 104(4):1526-1530. PubMed ID: 33591936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
    Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
    Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
    Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
    BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers.
    Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadisa A; Admasu D; Tesfaye E; Bates TA; Bulcha JT; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
    BMC Infect Dis; 2022 Mar; 22(1):261. PubMed ID: 35296265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-COV-2 seroprevalence among all healthcare workers in a tertiary hospital in Spain.
    Cantero M; Millán-Pérez R; Muñez E; Gómez-Lozano N; Anel-Pedroche J; Parra LM; Rodríguez ML; Asensio A
    Infect Dis (Lond); 2022 Jan; 54(1):8-15. PubMed ID: 34424122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of Anti-SARS-CoV-2 Antibodies Three Months Post Infection in Healthcare Professionals at an Oncology Hospital in Northern Portugal.
    Silva DF; Silva PD; Torgal A; Braga S; Rocha D; Ochoa C; Oliveira Á; Rocha L; Dias JM; Baldaque I
    Acta Med Port; 2021 Jun; 34(6):484-485. PubMed ID: 34715953
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care.
    Klevebro S; Bahram F; Elfström KM; Hellberg U; Hober S; Merid SK; Kull I; Nilsson P; Tornvall P; Wang G; Conneryd Lundgren K; Ponzer S; Dillner J; Melén E
    Scand J Public Health; 2021 Nov; 49(7):707-712. PubMed ID: 34148454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study.
    Ebinger JE; Botwin GJ; Albert CM; Alotaibi M; Arditi M; Berg AH; Binek A; Botting P; Fert-Bober J; Figueiredo JC; Grein JD; Hasan W; Henglin M; Hussain SK; Jain M; Joung S; Karin M; Kim EH; Li D; Liu Y; Luong E; McGovern DPB; Merchant A; Merin N; Miles PB; Minissian M; Nguyen TT; Raedschelders K; Rashid MA; Riera CE; Riggs RV; Sharma S; Sternbach S; Sun N; Tourtellotte WG; Van Eyk JE; Sobhani K; Braun JG; Cheng S
    BMJ Open; 2021 Feb; 11(2):e043584. PubMed ID: 33579769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.